Cross-sectional analysis identifies inflammatory and metabolic correlates of IL-17A in adults with HIV, suggesting new therapeutic targets.
Background Interleukin-17A (IL-17A) is a key cytokine in inflammation and autoimmunity. However, its systemic correlates, particularly in a high HIV burden population, are not fully elucidated. This study aimed to identify the sociodemographic, clinical, inflammatory, metabolic, and renal factors independently associated with plasma IL-17A levels. Methods This cross-sectional analysis enrolled a cohort of adults from Livingstone Teaching Hospital in Zambia. Sociodemographic and clinical variables were systematically collected. Associations between plasma IL-17A levels and a range of covariates were assessed using simple and multiple linear regression analyses in StatCrunch to identify independent correlates. Statistical significance was set at p<0.05. Results A cohort of 366 participants was analyzed, characterized by a predominance of females (70.2%) and people living with HIV (73.5%), the vast majority of whom were receiving integrase strand transfer inhibitors (INSTI)-based antiretroviral therapy. Initial bivariate analysis revealed weak associations between IL-17A and various metabolic and inflammatory markers. In the final multivariable model (Model 1), which included all significant univariate variables, five factors were independently associated with IL-17A: IFN-γ (β: 1.17, 95% CI: 1.01–1.33, p<0.0001), IL-1 (β: 1.60, 95% CI: 0.74–2.47, p=0.0004), IL-5 (β: -0.34, 95% CI: -0.65 – -0.040, p=0.0268), soluble ST2 (β: -26.01, 95% CI: -38.15 – -13.87, p<0.0001), and D-dimer (β: -0.006, 95% CI: -0.009 – -0.002, p=0.0012). Plasma potassium was not significant in this full model (β: 0.78, 95% CI: -3.99–5.56, p=0.744). HIV status was not an independent correlate (β: 95.73, 95% CI: -499.68–691.15, p=0.749). A second model (Model 2) was constructed by adjusting for HIV status only. In this model, plasma potassium was a significant independent correlate of IL-17A (β: 10.07, 95% CI: 4.39–15.76, p=0.0006), along with triglycerides, LDL cholesterol, VLDL, IL-6, TNF-α, IL-1, IL-5, soluble ST2, fasting glucose, and lymphocyte count. Conclusion In a comprehensive model, inflammatory markers (IFN-γ, IL-1, IL-5, sST2) and D-dimer were the independent correlates of IL-17A. The relationship between plasma potassium and IL-17A was context-dependent, significant only in a model excluding other inflammatory cytokines. HIV status was not independently associated with IL-17A when inflammatory markers were considered. These findings highlight complex immune interactions and warrant further investigation.
No takes yet. Share an insight, caveat, or question.
Chisompola et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: